SteadyMed Therapeutics

A specialty pharmaceutical company focused on developing drug products for orphan and high-value diseases.

Health Tech & Life Sciences
Acquired by United Therapeutics Corporation
Acquired Rehovot, Israel Founded 2005
Last updated 2026-07-26
Total raised
$89.6M
Last: Undisclosed Round 2017-04
Stage
Acquired
Founded
2005
Headcount
8
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

SteadyMed Ltd. was an Israeli specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet parenteral delivery needs. The company's lead product candidate was Trevyent, a drug-device combination product that combined SteadyMed's PatchPump technology with treprostinil to treat pulmonary arterial hypertension (PAH). SteadyMed was founded in Israel in 2005 within the Zisapel family's RAD Biomed incubator. While it had offices in San Ramon, California, much of its development was carried out in its Rehovot, Israel offices.

Funding history · 7 rounds · $89.6M total

2017-03
PIPE $30.0M
★ OrbiMed★ Deerfield Management★ Adage Capital Management★ Kingdon Capital Management
2016-06
PIPE $32.0M
★ OrbiMed★ Federated Investors★ Deerfield Management
2015-02
Follow-on PO Undisclosed
2014-12
A Round $12.2M
★ Federated Investors★ Deerfield Management
2013-03
Debt Financing $3.0M
★ Square 1 Bank
2012-08
Seed $10.4M
★ KB Partners★ Samson Venture Partners
2008-12
Pre-Seed $2.0M
★ Samson Venture Partners

Headcount over time

From 31 (2016-06) to 7 (2025-10) · -24 (-77%) · 5 points · source: Finder history + radar grounding
310 2016-06 2025-10

Q&A

What is SteadyMed Therapeutics' primary focus?
SteadyMed Therapeutics was a specialty pharmaceutical company focused on developing drug products for orphan and high-value diseases, particularly those with unmet parenteral delivery needs.
What was SteadyMed Therapeutics' lead product candidate?
SteadyMed Therapeutics' lead product candidate was Trevyent, a drug-device combination product that combined the company's PatchPump technology with treprostinil to treat pulmonary arterial hypertension (PAH).
When was SteadyMed Therapeutics founded and where was its primary development carried out?
SteadyMed Therapeutics was founded in Israel in June 2005 within the Zisapel family's RAD Biomed incubator. Much of its development was carried out in its Rehovot, Israel offices, despite having offices in San Ramon, California.
What was the total amount of funding raised by SteadyMed Therapeutics?
SteadyMed Therapeutics raised a total of $139 million USD in funding.
When did SteadyMed Therapeutics conduct a public offering and for what amount?
In March 2015, SteadyMed Therapeutics conducted a public offering, raising $40 million USD.
When was SteadyMed Therapeutics acquired and by which company?
SteadyMed Therapeutics was acquired by United Therapeutics Corporation in April 2018 for an amount of $216 million USD.
How many employees did SteadyMed Therapeutics have at the time of its acquisition?
SteadyMed Therapeutics had 29 employees in November 2018, shortly after its acquisition.
Who is a known co-founder of SteadyMed Therapeutics?
Ian Solomon is a co-founder of SteadyMed Therapeutics.

Team · 1

Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Sensing
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2CB2B

Tags

cardiovascularpulmonarymedical-technologiesdrug-deliverypharmaceuticalspumpsblood-pressuresensorspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesteadymed.com
LinkedInlinkedin.com/company/3176521

Identifiers & details

Legal nameSteadyMed Ltd.
Founded2005-6
Employees (exact)8
OfficesUSA
Status reasonAcquired (Inactive) by United Therapeutics Corporation on Apr 2018 - closed due to acquisition

Acquisitions & public offerings

Acquired by United Therapeutics Corporation 2018-04 $216.0M

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domainsteadymed.com

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)513698928
Statusמחוסלת מרצון — CLOSED
Corp typeישראלית חברה ציבורית
Incorporated2005-06-15
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2019
Active charges / liens0
Registry events0
Registered addressאופנהיימר 5 רחובות